Creative Planning’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$587K Buy
61,676
+11,896
+24% +$92.4K ﹤0.01% 2893
2025
Q4
$388K Sell
49,780
-38,697
-44% -$280K ﹤0.01% 3049
2025
Q3
$672K Buy
88,477
+2,280
+3% +$19K ﹤0.01% 2464
2025
Q2
$772K Buy
86,197
+8,748
+11% +$81.5K ﹤0.01% 2069
2025
Q1
$581K Sell
77,449
-5,776
-7% -$46.6K ﹤0.01% 2153
2024
Q4
$626K Buy
83,225
+33,878
+69% +$257K ﹤0.01% 2028
2024
Q3
$375K Buy
49,347
+2,734
+6% +$20.8K ﹤0.01% 2341
2024
Q2
$288K Buy
46,613
+20,014
+75% +$110K ﹤0.01% 2384
2024
Q1
$135K Buy
26,599
+12,987
+95% +$73K ﹤0.01% 2656
2023
Q4
$81.5K Buy
+13,612
New +$78.9K ﹤0.01% 2595
2021
Q2
Sell
-18,459
Closed -$188K 2116
2021
Q1
$188K Buy
+18,459
New +$190K ﹤0.01% 2114
2018
Q2
Sell
-18,350
Closed -$88K 2056
2018
Q1
$88K Buy
+18,350
New +$94.3K ﹤0.01% 1768
2017
Q3
Sell
-17,800
Closed -$99K 2056
2017
Q2
$99K Buy
17,800
+15,615
+715% +$95.1K ﹤0.01% 2001
2017
Q1
$18K Sell
2,185
-23,765
-92% -$165K ﹤0.01% 3187
2016
Q4
$164K Buy
25,950
+1,550
+6% +$8.06K ﹤0.01% 1520
2016
Q3
$108K Buy
24,400
+8,000
+49% +$32K ﹤0.01% 1797
2016
Q2
$47K Buy
16,400
+3,900
+31% +$12.1K ﹤0.01% 2167
2016
Q1
$35K Buy
12,500
+1,100
+10% +$4.88K ﹤0.01% 2341
2015
Q4
$118K Buy
11,400
+4,100
+56% +$40.8K ﹤0.01% 1532
2015
Q3
$83K Buy
+7,300
New +$97.4K ﹤0.01% 1697
2015
Q2
Sell
-800
Closed -$7K 1274
2015
Q1
$7K Hold
800
﹤0.01% 3377
2014
Q4
$10K Sell
800
-305
-28% -$3.37K ﹤0.01% 3106
2014
Q3
$11K Buy
1,105
+300
+37% +$3.68K ﹤0.01% 2880
2014
Q2
$10K Hold
805
﹤0.01% 2859
2014
Q1
$9K Buy
805
+5
+0.6% +$53 ﹤0.01% 2791
2013
Q4
$6K Hold
800
﹤0.01% 2758
2013
Q3
$6K Hold
800
﹤0.01% 2651
2013
Q2
$1K Buy
+800
New +$1.38K ﹤0.01% 2925

Other funds holding BCRX